1. Home
  2. NEUP vs BREA Comparison

NEUP vs BREA Comparison

Compare NEUP & BREA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEUP
  • BREA
  • Stock Information
  • Founded
  • NEUP 1996
  • BREA 2022
  • Country
  • NEUP United States
  • BREA Ireland
  • Employees
  • NEUP N/A
  • BREA N/A
  • Industry
  • NEUP
  • BREA Services-Misc. Amusement & Recreation
  • Sector
  • NEUP
  • BREA Consumer Discretionary
  • Exchange
  • NEUP Nasdaq
  • BREA Nasdaq
  • Market Cap
  • NEUP 12.7M
  • BREA 14.8M
  • IPO Year
  • NEUP N/A
  • BREA 2023
  • Fundamental
  • Price
  • NEUP $11.89
  • BREA $6.27
  • Analyst Decision
  • NEUP Strong Buy
  • BREA
  • Analyst Count
  • NEUP 1
  • BREA 0
  • Target Price
  • NEUP $21.00
  • BREA N/A
  • AVG Volume (30 Days)
  • NEUP 67.0K
  • BREA 5.7K
  • Earning Date
  • NEUP 08-28-2025
  • BREA 01-01-0001
  • Dividend Yield
  • NEUP N/A
  • BREA N/A
  • EPS Growth
  • NEUP N/A
  • BREA N/A
  • EPS
  • NEUP 0.00
  • BREA N/A
  • Revenue
  • NEUP $15,662,715.00
  • BREA $2,988,009.00
  • Revenue This Year
  • NEUP N/A
  • BREA N/A
  • Revenue Next Year
  • NEUP N/A
  • BREA N/A
  • P/E Ratio
  • NEUP $3.84
  • BREA N/A
  • Revenue Growth
  • NEUP N/A
  • BREA 151.51
  • 52 Week Low
  • NEUP $2.90
  • BREA $5.00
  • 52 Week High
  • NEUP $126.00
  • BREA $19.50
  • Technical
  • Relative Strength Index (RSI)
  • NEUP 67.40
  • BREA 47.86
  • Support Level
  • NEUP $6.82
  • BREA $5.71
  • Resistance Level
  • NEUP $13.25
  • BREA $6.56
  • Average True Range (ATR)
  • NEUP 1.32
  • BREA 0.26
  • MACD
  • NEUP 0.44
  • BREA -0.02
  • Stochastic Oscillator
  • NEUP 77.78
  • BREA 53.18

About NEUP Neuphoria Therapeutics Inc. Common Stock

Neuphoria Therapeutics Inc is a clinical stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder.

About BREA Brera Holdings PLC

Brera Holdings PLC focused on expanding social impact football by developing a international portfolio of emerging football clubs with increased opportunities to earn tournament prizes, gain sponsorships, and provide other professional football and related consulting services.

Share on Social Networks: